Systemically administrered EGRFvIII-targeted bispecific antibody as an immunotherapeutic for glioblastoma.
Administered By
Awarded By
Contributors
- Bigner, Darell Doty Collaborator
- Burnett, Bruce Kendall Collaborator
- Dewhirst, Mark Wesley Collaborator
- Gersbach, Charles Collaborator
- Herndon II, James Emmett Collaborator
- Kuan, Chien-Tsun Collaborator
- Sampson, John Howard Principal Investigator
- Weinhold, Kent James Collaborator
- Zalutsky, Michael Rod Collaborator
Start/End
- March 1, 2015 - February 28, 2019